Skip to main content
Equibles

BMEZ · BlackRock Health Sciences Term Trust

Track BMEZ — free

Use BMEZ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BMEZ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$16.54 +0.07 (+0.43%) At close · Oct 5
Rebalance outlook locked
Market Cap
$1.06B
Shares
62.50M
Volume · Oct 5 134.81K Avg daily vol (3M) 143.43K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$16.54 Open$16.51 Day$16.42–16.65 52W close$13.76–17.25 Avg vol 30d142K Short int84K · 0.1% float · 1.0d Short vol39% DataJan 2020–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
8.0%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+13.2%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +9%
above
Price vs 50-day avg +1%
above
RSI (14) 48
neutral
MACD trend Negative
52-week position 80%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −3%
trailing
6-month return +12%
trailing
YTD return +10%
this year
Relative strength 0%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $16 › 200d $15 — 50d above 200d
Institutional flow Flat
0% holders QoQ · +13 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.13% of float · ▲ +178.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
88 holders — mid 3-yr range
Squeeze score 47
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 17%
annualized · 1-yr
Max drawdown −13%
past year
ATR 1.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+9% Bullish
Price vs 50-day avg
+1% Bullish
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
80% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $16 › 200d $15 — 50d above 200d
Institutional flow Flat
0% holders QoQ · +13 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.13% of float · ▲ +178.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
88 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $14 Now $17 · 80% Range high $17
vs 200-day avg +9% vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BMEZ
BlackRock Health Sciences Term Trust
this stock
$1.06B +9.9% — — 0.1%
BLK
BlackRock, Inc.
 $347.03B -0.4% +16.2% 25.6 0.6%
KKR
KKR & Co. Inc.
 $86.77B -29.4% -11.0% — 1.5%
BX
Blackstone Inc.
 $85.57B -27.6% +9.2% 25.6 2.6%
BN
BROOKFIELD Corp /ON/
 $81.46B -19.7% — — 0.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
88
% held
26.7%
Net QoQ
+1.7M sh
Top holder
MORGAN STANLEY
Held Float
View
Held by Funds
Fund positions
9
View
Short & Settlement
Short Interest Rising
Shares short
83.9K
Days to cover
1.0d
Change
+53.8K sh
View
Short Volume
Short vol %
39%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
942
Value
$16.0K
As of
Sep 9, 2026
View
Off-Exchange
Off-exchange %
72.8%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
DEF 14A
Filed
Jun 2, 2026
This year
1
View

Performance

5D 20D 120D MTD YTD
BMEZ -1.7% -2.5% +12.0% -1.0% +9.9%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -2.9% -3.1% +0.4% -2.6% -3.7%

Capital returns

Latest dividend
$0.11 / share · ex Sep 15, 2026
Declared · upcoming
$0.11 / share · ex Oct 15, 2026
Cut 32.5%
Paid (TTM)
$1.32 / share · 12 payouts
Dividend yield (TTM, derived)
7.98%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1785971 CUSIP 09260E105